Consequently, this study suggests that the therapeutic effect of SB on HCC is mainly achieved by targeting the p53 signaling pathway to regulate cell cycle progression, enhance tumor cell apoptosis, and regulate the MAPK signaling pathway and T cell-mediated tumor immunity, which are closely related to the occurrence and deterioration of HCC. Here, TP53 is linked to hepatocellular carcinoma.